
Ananta Medicare, founded in 1999, has evolved into a dynamic pharmaceutical group with three state-of-the-art GMP-certified facilities in Sri Ganganagar, India—manufacturing cephalosporin injectables , oral dosage forms, and herbal dietary supplements . Underpinning its R&D strategy is a dual focus: broadening its therapeutic pipeline across cardiovascular, endocrine, neurological, infectious, dermatological, and urogenital areas, and clinically validating the efficacy of its herbal and nutraceutical offerings .
Ananta conducts rigorous quality checks at every production stage—from raw material sourcing through packaging—ensuring compliance with WHO, ISO, HACCP, and PIC/S standards. The company also actively engages in international scientific forums and clinical studies, maintaining more than 200 SKUs and expanding into over 20 countries . Fueled by innovation and global collaboration, Ananta’s R&D efforts are shaping its mission to deliver accessible, high-quality pharmaceuticals and wellness solutions worldwide.